Home » Topics » Regulatory

Regulatory
RSS

FDA approves Bayer's Stivarga for treatment of metastatic colorectal cancer

Sep. 28, 2012

Regeneron's Eylea receives second U.S. approval

Sep. 27, 2012

FDA approves denosumab in new indication

Sep. 25, 2012

FDA approves production of [11C]-choline injection for PET imaging

Sep. 14, 2012

FDA approves Genzyme's MS therapeutic

Sep. 13, 2012

FDA approves Pfizer's bosutinib for CML

Sep. 5, 2012

Teduglutide receives European marketing authorization for short bowel syndrome

Sep. 5, 2012

FDA approves Xtandi for metastatic castration-resistant prostate cancer

Sep. 3, 2012

New drug approved for IBS-C and CIC

Aug. 31, 2012

Nucynta ER approved for new indication in U.S.

Aug. 30, 2012